CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | Ballal Rahul D. Director | Exercise or conversion | +2,816 | 15,230 | ||
| 2026-06-18 | Ballal Rahul D. Director | Exercise or conversion · Restricted stock units | −2,816 | 0 | ||
| 2026-06-18 | Ballal Rahul D. Director | Grant or award · Restricted stock units | +2,927 | 2,927 | ||
| 2026-06-18 | Ballal Rahul D. Director | Grant or award · Stock options (right to buy) | +14,950 | 14,950 | ||
| 2025-08-11 | Ballal Rahul D. Director | Exercise or conversion | +2,302 | 12,414 | ||
| 2025-08-11 | Ballal Rahul D. Director | Exercise or conversion · Restricted stock units | −2,302 | 0 | ||
| 2025-06-20 | Ballal Rahul D. Director | Exercise or conversion | +2,120 | 10,112 | ||
| 2025-06-20 | Ballal Rahul D. Director | Exercise or conversion · Restricted stock units | −2,120 | 0 | ||
| 2025-06-18 | Ballal Rahul D. Director | Grant or award · Restricted stock units | +2,816 | 2,816 | ||
| 2025-06-18 | Ballal Rahul D. Director | Grant or award · Stock options (right to buy) | +15,768 | 15,768 | ||
| 2024-11-08 | Ballal Rahul D. Director | Exercise or conversion 10b5-1 | +10,000 | $25.99 | $260K | 17,992 |
| 2024-11-08 | Ballal Rahul D. Director | Sale 10b5-1 | −3,571 | $57.24 | $204K | 14,421 |
| 2024-11-08 | Ballal Rahul D. Director | Sale 10b5-1 | −4,929 | $58.57 | $289K | 9,492 |
| 2024-11-08 | Ballal Rahul D. Director | Sale 10b5-1 | −1,500 | $59.21 | $89K | 7,992 |
| 2024-11-08 | Ballal Rahul D. Director | Exercise or conversion · Stock option (right to buy) 10b5-1 | −10,000 | 17,947 | ||
| 2024-11-07 | Ballal Rahul D. Director | Exercise or conversion 10b5-1 | +10,000 | $25.99 | $260K | 17,992 |
| 2024-11-07 | Ballal Rahul D. Director | Sale 10b5-1 | −8,132 | $53.32 | $434K | 9,860 |
| 2024-11-07 | Ballal Rahul D. Director | Sale 10b5-1 | −1,868 | $54.41 | $102K | 7,992 |
| 2024-11-07 | Ballal Rahul D. Director | Exercise or conversion · Stock option (right to buy) 10b5-1 | −10,000 | 27,947 | ||
| 2024-08-11 | Ballal Rahul D. Director | Exercise or conversion | +2,302 | 7,992 |
Page 1 of 2 · 31 trades